2He Q, Zou L, Zhang PA, et al. Concentration of thymidine kinase 1 in serus ( STK1 )is a more sensitive proliferation marker in human solid tumors than its activity[J]. Oncd Rep,2005,14 ( 4 ): 1013.
4Gronowitz SJ,Kallander CFR,Diderholm H,et al. Application of an in vitro assay serum thymidine kinase: results on viral disease and malignancies in humans [J]. Int J Cancer,1984,33(1): 5-12.
5He Q, Zhang P, Zou L, et al. Concentration of thymidine kinase 1 in serum (S-TK1) is a more sensitive proliferation marker in human solid tumors than its activity [ J ]. Oncol Rep, 2005, 14 (4) : 1013- 1019.
7Hallek M,Touitou Y, Levi F, et al. Serum thymidine kinase levels are elevated exhibit diurnal variations in patients with advanced ovarian cancer[ J]. Clin Chim Acta, 1997,267 (2) : 155-166.
8Zhang F, Li H, Pendleton AR, et al. Thymidine kinase 1 immunoassay: a potential marker for breast cancer[J]. Cancer Detect Prey,2001,25( 1 ) :8-15.
9He Q, Skog S, Wang N, et al. Characterization of a peptide antibody against a C-terminal part of human and mouse cytosolic thymidine kinase, which is a marker for cell proliferation [ J]. Eur J Cell Biol, 1996,70(2 ) : 117-124.
10Zou L, Zhang PA, Zou S, et al. The half-life of thymidine kinase 1 in serum measured by ECL dot blot: a potential marker for monitoring the response to surgery of patients with gastric cancer[ J]. Biol Marker, 2003,7(2) :135-140.
